Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (18.754)

101

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Park, S. | Kim, T. | Han, J. | +21

102

Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer : Phase III ERMES Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Pinto, C. | Orlandi, A. | Normanno, N. | +17

103

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

104

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors : Final Results of CheckMate 722

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mok, T. | Nakagawa, K. | Park, K. | +20

105

Patient-Reported Outcomes in OlympiA : A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ganz, P. | Bandos, H. | Španić, T. | +43

106

Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains : results from two phase 3 randomised studies, BE MOBILE 1 and 2

enthalten in: RMD open | 2024

von Navarro-Compán, V. | Ramiro, S. | Deodhar, A. | +9

107

Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren : a randomised controlled trial (ViDiKids)

enthalten in: BMJ paediatrics open | 2024

von Middelkoop, K. | Micklesfield, L. | Stewart, J. | +13

108

Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older

enthalten in: Vaccine | 2024

von Yonekawa, M. | Watanabe, T. | Kogawara, O. | +9

109

Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age : Results of a randomized phase 3 study

enthalten in: Vaccine | 2024

von Baker, J. | Aliabadi, N. | Munjal, I. | +8

110

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS) : a randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Giamarellos-Bourboulis, E. | Siampanos, A. | Bolanou, A. | +29

ErratumIn: Lancet Respir Med. 2024 Feb 21;:. - PMID 38401557